Abstract
To estimate whether STI571 inhibits the expression of vascular endothelial growth factor (VEGF) in the gastrointestinal stromal tumor (GIST) cells. We used GIST cell line, GIST-T1. It has a heterogenic 57-bp deletion in exon 11 to produce a mutated c-KIT, which results in constitutive activation of c-KIT. Cells were treated with/without STI571 or stem cell factor (SCF). Transcription and expression of VEGF were determined by RT-PCR and flow cytometry or Western blotting, respectively. Activated c-KIT was estimated by immunoprecipitation analysis. Cell viability was determined by MTT assay. Activation of c-KIT was inhibited by STI571 treatment. VEGF was suppressed at both the transcriptional and translational levels in a temporal and dose-dependent manner by STI571. SCF upregulated the expression of VEGF and it was inhibited by STI571. STI571 also reduced the cell viability of the GIST-T1 cells, as determined by MTT assay. Activation of c-KIT in the GIST-T1 regulated the expression of VEGF and it was inhibited by STI571. STI571 has antitumor effects on the GIST cells with respect to not only the inhibition of cell growth, but also the suppression of VEGF expression.
References
Jan 26, 1995·Nature·J D HuizingaA Bernstein
Feb 7, 1998·Science·S HirotaY Kitamura
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·B J LongleyY Ma
Jun 11, 1999·The American Journal of Pathology·Q TianC A Moskaluk
May 22, 2001·Molecular and Cellular Biology·E LaughnerG L Semenza
Aug 30, 2001·Oncogene·D A TuvesonG D Demetri
Nov 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A J KnoxL Pang
Jan 24, 2002·Cancer Letters·Kentaro NakayamaYuji Takebayashi
May 11, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Takahiro TaguchiKazunari Yuri
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Dec 10, 2002·Science·Gary L Johnson, Razvan Lapadat
Apr 17, 2003·Oncology·Ryoji TakahashiKazuaki Chayama
Jun 26, 2003·Cancer Science·Yukihiko KitamuraToshirou Nishida
Mar 17, 2004·Cancer Treatment Reviews·Juan Angel Fresno VaraManuel González-Barón
Citations
Sep 18, 2010·The Journal of Medical Investigation : JMI·Hajime NakataniKazuhiro Hanazaki
Nov 20, 2015·Frontiers in Oncology·Monika Ehnman, Olle Larsson
Dec 3, 2016·PloS One·Feng PanYi Wang
Aug 29, 2020·PPAR Research·Siyue DuKay-Dietrich Wagner
Oct 13, 2006·World Journal of Gastroenterology : WJG·Toshiyuki NakayamaIchiro Sekine
Mar 6, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Masakazu ImamuraMasazumi Tsuneyoshi
Dec 11, 2007·Virchows Archiv : an International Journal of Pathology·Rosario S RiveraNoriyuki Nagai
Apr 16, 2009·Irish Journal of Medical Science·T B WangW G Dong
Dec 13, 2006·Expert Opinion on Investigational Drugs·Alex KiselyovSergey E Tkachenko
Jun 11, 2011·Clinical and Experimental Medicine·Tian-bao WangWen-guang Dong
Feb 19, 2009·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·F BergerM F Reiser
Aug 14, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Bilge CanBedri Kandemir
Jul 2, 2009·Reproduction : the Official Journal of the Society for the Study of Fertility·Sridurga Mithraprabhu, Kate L Loveland
May 29, 2013·Acta Oncologica·Mona-Elisabeth RevheimTherese Seierstad
May 21, 2010·The Tohoku Journal of Experimental Medicine·Ying HuangBaohua Liu
Aug 21, 2008·Der Radiologe·F Berger, M Reiser
Nov 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John C McAuliffeJonathan C Trent